Free Trial
NASDAQ:ACHV

Achieve Life Sciences (ACHV) Stock Price, News & Analysis

Achieve Life Sciences logo
$2.20 -0.06 (-2.65%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$2.15 -0.05 (-2.05%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Achieve Life Sciences Stock (NASDAQ:ACHV)

Key Stats

Today's Range
$2.15
$2.29
50-Day Range
$2.20
$4.21
52-Week Range
$1.84
$5.31
Volume
817,661 shs
Average Volume
260,385 shs
Market Capitalization
$76.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.33
Consensus Rating
Strong Buy

Company Overview

Achieve Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

ACHV MarketRank™: 

Achieve Life Sciences scored higher than 33% of companies evaluated by MarketBeat, and ranked 2296th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Achieve Life Sciences has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Achieve Life Sciences has received no research coverage in the past 90 days.

  • Read more about Achieve Life Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Achieve Life Sciences are expected to grow in the coming year, from ($1.17) to ($1.16) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Achieve Life Sciences is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Achieve Life Sciences is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Achieve Life Sciences has a P/B Ratio of 3.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Achieve Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    8.83% of the float of Achieve Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Achieve Life Sciences has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Achieve Life Sciences has recently increased by 13.36%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Achieve Life Sciences does not currently pay a dividend.

  • Dividend Growth

    Achieve Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.83% of the float of Achieve Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Achieve Life Sciences has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Achieve Life Sciences has recently increased by 13.36%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Achieve Life Sciences has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Achieve Life Sciences this week, compared to 3 articles on an average week.
  • Search Interest

    Only 2 people have searched for ACHV on MarketBeat in the last 30 days. This is a decrease of -78% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Achieve Life Sciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Achieve Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.00% of the stock of Achieve Life Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 33.52% of the stock of Achieve Life Sciences is held by institutions.

  • Read more about Achieve Life Sciences' insider trading history.
Receive ACHV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

ACHV Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

ACHV Stock Analysis - Frequently Asked Questions

Achieve Life Sciences' stock was trading at $3.52 at the beginning of the year. Since then, ACHV shares have decreased by 37.5% and is now trading at $2.20.

Achieve Life Sciences, Inc. (NASDAQ:ACHV) posted its quarterly earnings data on Tuesday, May, 13th. The biopharmaceutical company reported ($0.37) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.37).
Read the conference call transcript
.

Shares of Achieve Life Sciences reverse split on Friday, July 31st 2020.The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Achieve Life Sciences investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), Moderna (MRNA), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
5/13/2025
Today
7/04/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ACHV
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.33
High Stock Price Target
$20.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+551.5%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$39.83 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.61 per share
Price / Book
3.61

Miscellaneous

Free Float
33,644,000
Market Cap
$76.31 million
Optionable
Optionable
Beta
1.51

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:ACHV) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners